| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 1,159,600 | 1,128,700 | 1,099,900 | 1,279,500 | | Cost of Revenue | 853,800 | 859,000 | 876,900 | 1,041,800 | | | Gross Profit | 305,800 | 269,700 | 223,000 | 237,700 | | | Operating Expenses | | Research Development | 24,300 | 25,100 | 27,400 | 30,400 | | Selling General and Administrative | 163,500 | 169,200 | 173,600 | 255,100 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 118,000 | 75,400 | 22,000 | (47,800) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (3,300) | 3,000 | (6,700) | (8,700) | | Earnings Before Interest And Taxes | 114,700 | 78,400 | 15,300 | (56,500) | | Interest Expense | 25,400 | 21,200 | 21,800 | 20,800 | | Income Before Tax | 89,300 | 57,200 | (6,500) | (77,300) | | Income Tax Expense | 26,200 | 16,600 | 15,600 | (19,300) | | Minority Interest | (6,800) |
-
|
-
|
-
| | | | Net Income From Continuing Ops | 56,300 | 40,600 | (22,100) | (58,000) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 56,300 | 40,600 | (22,100) | (58,000) | | Preferred Stock And Other Adjustments | 4,800 | (2,500) | (2,300) |
-
| | | Net Income Applicable To Common Shares | $61,100 | $38,100 | ($24,400) | ($58,000) |
|
0.31% Nasdaq 
0.05%
Income Statement
